Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology.
Stegmayr C, Stoffels G, Filß C, Heinzel A, Lohmann P, Willuweit A, Ermert J, Coenen HH, Mottaghy FM, Galldiks N, Langen KJ.
Stegmayr C, et al. Among authors: heinzel a.
Nucl Med Biol. 2021 Jan;92:78-84. doi: 10.1016/j.nucmedbio.2020.02.006. Epub 2020 Feb 19.
Nucl Med Biol. 2021.
PMID: 32113820
Review.